Candidate surrogate end points for ESRD after AKI

Journal of the American Society of Nephrology

Volumn 27, Issue 9, 2016, Pages 2851-2859

  Grams, Morgan E ^a,b   Sang, Yingying ^b   Coresh, Josef ^a,b,c   Ballew, Shoshana H ^b   Matsushita, Kunihiro ^b   Levey, Andrew S ^d   Greene, Tom H ^e   Molnar, Miklos Z ^f   Szabo, Zoltan ^g,h   Kalantar Zadeh, Kamyar ^i,j   Kovesdy, Csaba P ^f,k  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Departments of Epidemiology   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^h LINKÖPING UNIVERSITY   (Sweden)

ⁱ Harold Simmons Center for Chronic Disease Research and Epidemiology   (Sweden)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CREATININE BLOOD LEVEL; EAR NOSE THROAT SURGERY; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MIDDLE AGED; MORTALITY; MORTALITY RISK; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; SURVIVAL TIME; SURVIVOR; UNITED STATES; BLOOD; COMPLICATION; DISEASE COURSE; GLOMERULUS FILTRATION RATE; KIDNEY FAILURE, CHRONIC; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC;

BIOMARKERS; CREATININE; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

EID: 84964017133     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015070829     Document Type: Article

References (33)

1. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J: Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104: 343-348, 1998
2. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16: 3365-3370, 2005
3. Thakar CV: Perioperative acute kidney injury. Adv Chronic Kidney Dis 20: 67-75, 2013
4. Thakar CV, Christianson A, Freyberg R, Almenoff P, Render ML: Incidence and outcomes of acute kidney injury in intensive care units: A Veterans Administration study. Crit Care Med 37: 2552-2558, 2009
5. Hsu CY: Yes, AKI truly leads to CKD. J Am Soc Nephrol 23: 967-969, 2012
6. Rifkin DE, Coca SG, Kalantar-Zadeh K: Does AKI truly lead to CKD? J Am Soc Nephrol 23: 979-984, 2012
7. Kellum JA, Lameire N; KDiGO AKI Guideline Work Group: Diagnosis, evaluation, and management of acute kidney injury: A KDiGOsummary (Part 1). Crit Care 17: 204, 2013
8. Grams ME, Sang Y, Ballew SH, Gansevoort RT, Kimm H, Kovesdy CP, Naimark D, Oien C, Smith DH, Coresh J, Sarnak MJ, Stengel B, Tonelli M; CKD Prognosis Consortium: A meta-analysis of the association of estimated gfr, albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis 66: 591-601, 2015
9. JamesMT, GramsME,WoodwardM, Elley CR, Green JA, Wheeler DC, de Jong P, Gansevoort RT, Levey AS, Warnock DG, Sarnak MJ; CKD Prognosis Consortium: A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury. Am J Kidney Dis 66: 602-612, 2015
10. Coca SG: Is it AKI or nonrecovery of renal function that is important for long-term outcomes? Clin J Am Soc Nephrol 8: 173-176, 2013
11. Coresh J, Turin TC,Matsushita K, Sang Y, BallewSH, Appel LJ, Arima H, Chadban SJ, CirilloM, DjurdjevO,Green JA, HeineGH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; CKD Prognosis Consortium: Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311: 2518-2531, 2014
12. Levey AS, Inker LA,Matsushita K, Greene T,Willis K, Lewis E, de Zeeuw D, Cheung AK, Coresh J:GFR decline as an end point for clinical trials in CKD: A scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 64: 821-835, 2014
13. Thompson A, Lawrence J, Stockbridge N: GFR decline as an end point in trials of CKD: A viewpoint from the FDA. AmJ Kidney Dis 64: 836-837, 2014
14. Greene T, Teng CC, Inker LA, Redd A, Ying J, Woodward M, Coresh J, Levey AS: Utility and validity of estimated GFR-based surrogate time-to-event end points in CKD: A simulation study. Am J Kidney Dis 64: 867-879, 2014
15. Inker LA, Lambers Heerspink HJ, Mondal H, Schmid CH, Tighiouart H, Noubary F, Coresh J,Greene T, Levey AS:GFR decline as an alternative end point to kidney failure in clinical trials: A meta-analysis of treatment effects from 37 randomized trials. AmJ Kidney Dis 64: 848-859, 2014
16. Lambers Heerspink HJ, Tighiouart H, Sang Y, Ballew S, Mondal H, Matsushita K, Coresh J, Levey AS, Inker LA: GFR decline and subsequent risk of established kidney outcomes: A meta-analysis of 37 randomized controlled trials. Am J Kidney Dis 64: 860-866, 2014
17. Lambers Heerspink HJ, Weldegiorgis M, Inker LA, Gansevoort R, Parving HH, Dwyer JP, Mondal H, Coresh J, Greene T, Levey AS, de Zeeuw D: Estimated GFR decline as a surrogate end point for kidney failure: A post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT). Am J Kidney Dis 63: 244-250, 2014
18. Stevens LA, Greene T, Levey AS: Surrogate end points for clinical trials of kidney disease progression. Clin J AmSocNephrol 1: 874-884, 2006
19. Levey AS, Cattran D, FriedmanA,MillerWG,Sedor J, Tuttle K, Kasiske B, Hostetter T: Proteinuria as a surrogate outcome in CKD: Report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 54: 205-226, 2009
20. Boekholdt SM, Arsenault BJ,Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM Jr., Ridker PM, Kastelein JJ: Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: A meta-analysis. JAMA 307: 1302-1309, 2012
21. Kidney Disease: Improving Global Outcomes: Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3: 1-150, 2013
22. Sawhney S,Mitchell M, Marks A, Fluck N, Black C: Long-term prognosis after acute kidney injury (AKI): What is the role of baseline kidney function and recovery? A systematic review. BMJ Open 5: e006497, 2015
23. Pannu N, James M, Hemmelgarn B, Klarenbach S; Alberta Kidney Disease Network: Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge. Clin J Am Soc Nephrol 8: 194-202, 2013
24. Swaminathan M, Hudson CC, Phillips-Bute BG, Patel UD, Mathew JP, Newman MF, Milano CA, Shaw AD, Stafford-Smith M: Impact of early renal recovery on survival after cardiac surgery-associated acute kidney injury. Ann Thorac Surg 89: 1098-1104, 2010
25. Garg AX, Devereaux PJ, Yusuf S, Cuerden MS, Parikh CR, Coca SG, WalshM,Novick R, Cook RJ, Jain AR, Pan X, NoiseuxN, Vik K, StolfNA, Ritchie A, Favaloro RR, Parvathaneni S, Whitlock RP,Ou Y, LawrenceM, Lamy A; CORONARY Investigators: Kidney function after off-pump or on-pump coronary artery bypass graft surgery: A randomized clinical trial. JAMA 311: 2191-2198, 2014
26. MeybohmP, Bein B, BrosteanuO, Cremer J, GruenewaldM, Stoppe C, Coburn M, Schaelte G, Böning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schön J, SanderM, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K; RIPHeart Study Collaborators: A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373: 1397-1407, 2015
27. Weisbord SD, Gallagher M, Kaufman J, Cass A, Parikh CR, Chertow GM, Shunk KA,McCullough PA, FineMJ,Mor MK, Lew RA, Huang GD, Conner TA, Brophy MT, Lee J, Soliva S, Palevsky PM: Prevention of contrast-induced AKI: A review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Clin J Am Soc Nephrol 8: 1618-1631, 2013
28. Gosmanova EOLJ, Lu JL, Streja E, Cushman WC, Kalantar-Zadeh K, Kovesdy CP: Association of medical treatment nonadherence with allcause mortality in newly treated hypertensive US veterans. Hypertension 64: 951-957, 2014
29. Kovesdy CP, Norris KC, Boulware LE, Lu JL,Ma JZ, Streja E,MolnarMZ, Kalantar-Zadeh K: Association of race withmortality and cardiovascular events in a large cohort of US veterans. Circulation 132: 1538-1548, 2015
30. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
31. GramsME, Sang Y, Coresh J, Ballew S, Matsushita K, Molnar MZ, Szabo Z, Kalantar-Zadeh K, Kovesdy CP: Acute kidney injury after major surgery: A retrospective analysis of Veterans Health Administration Data [published online ahead of print September 1, 2015]. Am J Kidney Dis 10. 1053/j. ajkd. 2015. 07. 022
32. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K: Blood pressure and mortality in U. S. veterans with chronic kidney disease: A cohort study. Ann Intern Med 159: 233-242, 2013
33. Molnar MZ, Kalantar-Zadeh K, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Quarles DL, Kovesdy CP: Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol 63: 650-658, 2014